// App-Quantinova.ai

: Dynamic Personalized Assessment of Outcome in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Koji Sasaki

Principal Investigators

  • Farhad Ravandi

  • Nicholas J Short

  • Guillermo Garcia-Manero

  • Naval G. Daver

  • Tapan M. Kadia

  • Marina Y. Konopleva

  • Nitin Jain

  • Ghayas C. Issa

  • Victoria Jeanis

  • Joie Alvarez

  • Maria Khouri

  • Patrice Nasnas

  • Rebecca E. Garris

  • William G. Wierda

  • Philip A. Thompson

  • Naveen Pemmaraju

  • Jorge E. Cortes

  • Susan M. O'Brien

  • Hagop M. Kantarjian

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • UC Irvine Health, Chao Family Comprehensive Cancer Center, Orange, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Hypercarotenemia and vitamin A deficiency

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Vincristine

  • Doxorubicin

  • Ponatinib

  • dasatinib

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved